Sanofi-Aventis Executive Says Demand For H1N1 Vaccine From Western Countries May Limit Supply For Developing Countries

Also on Wednesday Chris Viehabcher, chief executive of the vaccine maker Sanofi-Aventis, cautioned that the demand for an H1N1 (swine) flu vaccine in developed countries could compromise the company's ability to supply the vaccine to poor countries, the Financial Times reports. Playing "down suggestions that vaccine-makers stood to make large profits from the swine flu pandemic," Viehabcher "warned that extended manufacturing to meet growing demand from the west could affect production required for poor countries in the next southern hemisphere winter" (Jack, 7/29).

This article is republished with kind permission from our friends at The Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery of in-depth coverage of health policy developments, debates and discussions. The Kaiser Daily Health Policy Report is published for Kaisernetwork, a free service of The Henry J. Kaiser Family Foundation. 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.